Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser

BACKGROUND/AIMS: Clinical trials suggest anti-vascular endothelial growth factor is more effective than intravitreal dexamethasone as treatment for macular oedema secondary to branch retinal vein occlusion. This study asks if ‘real world’ data from a larger and more diverse population, followed for...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Ophthalmol
Päätekijät: Gale, Richard, Pikoula, Maria, Lee, Aaron Y, Denaxas, Spiros, Egan, Catherine, Tufail, Adnan, Taylor, Paul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2021
Aiheet:
Clinical Science
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8005793/
https://ncbi.nlm.nih.gov/pubmed/32532760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-315836
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia